US5763597A
(en)
*
|
1989-09-15 |
1998-06-09 |
Metabasis Therapeutics, Inc. |
Orally active adenosine kinase inhibitors
|
US5864033A
(en)
*
|
1989-09-15 |
1999-01-26 |
Metabasis Therapeutics, Inc. |
Adenosine kinase inhibitors
|
US5721356A
(en)
*
|
1989-09-15 |
1998-02-24 |
Gensia, Inc. |
Orally active adenosine kinase inhibitors
|
US5763596A
(en)
*
|
1989-09-15 |
1998-06-09 |
Metabasis Therapeutics, Inc. |
C-4' modified adenosine kinase inhibitors
|
US5795977A
(en)
*
|
1989-09-15 |
1998-08-18 |
Metabasis Therapeutics, Inc. |
Water soluble adenosine kinase inhibitors
|
US5726302A
(en)
*
|
1989-09-15 |
1998-03-10 |
Gensia Inc. |
Water soluble adenosine kinase inhibitors
|
US5674998A
(en)
*
|
1989-09-15 |
1997-10-07 |
Gensia Inc. |
C-4' modified adenosine kinase inhibitors
|
ES2109796T3
(es)
*
|
1994-05-03 |
1998-01-16 |
Ciba Geigy Ag |
Derivados de pirrolopirimidilo con efecto antiproliferante.
|
US5665721A
(en)
*
|
1995-06-07 |
1997-09-09 |
Abbott Laboratories |
Heterocyclic substituted cyclopentane compounds
|
US6395733B1
(en)
|
1995-06-07 |
2002-05-28 |
Pfizer Inc |
Heterocyclic ring-fused pyrimidine derivatives
|
US6143749A
(en)
*
|
1995-06-07 |
2000-11-07 |
Abbott Laboratories |
Heterocyclic substituted cyclopentane compounds
|
BR9609467A
(pt)
*
|
1995-07-11 |
1999-03-02 |
Astra Pharma Prod |
Composto uso de um composto composição farmacéutica e processos para preparação de um composto e tratamento de distúrbios de agregação planquetária
|
EP0888349B1
(en)
*
|
1996-01-23 |
2002-05-22 |
Novartis AG |
Pyrrolopyrimidines and processes for their preparation
|
JP4255138B2
(ja)
*
|
1996-05-24 |
2009-04-15 |
湧永製薬株式会社 |
脳疾患治療剤
|
AU3255097A
(en)
*
|
1996-07-05 |
1998-02-02 |
Novo Nordisk A/S |
Novel (n)-alkoxyadenine derivatives acting as cytokine inhibitors
|
US5824657A
(en)
*
|
1997-03-18 |
1998-10-20 |
Cubist Pharmaceuticals, Inc. |
Aminoacyl sulfamides for the treatment of hyperproliferative disorders
|
US7863444B2
(en)
|
1997-03-19 |
2011-01-04 |
Abbott Laboratories |
4-aminopyrrolopyrimidines as kinase inhibitors
|
CA2234342A1
(en)
*
|
1997-04-10 |
1998-10-10 |
Kyowa Hakko Kogyo Co., Ltd. |
Pancreatitis remedy
|
US6713474B2
(en)
|
1998-09-18 |
2004-03-30 |
Abbott Gmbh & Co. Kg |
Pyrrolopyrimidines as therapeutic agents
|
BR9913887A
(pt)
*
|
1998-09-18 |
2001-10-23 |
Basf Ag |
Composto, e, métodos de inibir a atividade de proteìna quinase, de tratar um paciente que tenha uma condição que seja mediada pela atividade da proteìna quinase e de diminuir a fertilidade em um paciente
|
TWI229674B
(en)
|
1998-12-04 |
2005-03-21 |
Astra Pharma Prod |
Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
|
CA2385747A1
(en)
|
1999-09-17 |
2001-03-22 |
Gavin C. Hirst |
Pyrazolopyrimidines as therapeutic agents
|
US7071199B1
(en)
|
1999-09-17 |
2006-07-04 |
Abbott Gmbh & Cco. Kg |
Kinase inhibitors as therapeutic agents
|
AU1929801A
(en)
*
|
1999-12-16 |
2001-06-25 |
Alcon Inc. |
Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage
|
WO2001072751A1
(en)
*
|
2000-03-29 |
2001-10-04 |
Knoll Gesellschaft Mit Beschraenkter Haftung |
Pyrrolopyrimidines as tyrosine kinase inhibitors
|
GB0100622D0
(en)
|
2001-01-10 |
2001-02-21 |
Vernalis Res Ltd |
Chemical compounds V111
|
GB0100623D0
(en)
*
|
2001-01-10 |
2001-02-21 |
Vernalis Res Ltd |
Chemical compounds IV
|
DE10238724A1
(de)
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
Alkyl-substituierte Pyrazolpyrimidine
|
DE10238722A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse
|
EP1633756B1
(en)
|
2003-04-09 |
2008-12-24 |
Biogen Idec MA Inc. |
A2a adenosine receptor antagonists
|
US7285550B2
(en)
|
2003-04-09 |
2007-10-23 |
Biogen Idec Ma Inc. |
Triazolotriazines and pyrazolotriazines and methods of making and using the same
|
WO2004092177A1
(en)
|
2003-04-09 |
2004-10-28 |
Biogen Idec Ma Inc. |
Triazolopyrazines and methods of making and using the same
|
PE20060272A1
(es)
|
2004-05-24 |
2006-05-22 |
Glaxo Group Ltd |
(2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
|
US9512125B2
(en)
|
2004-11-19 |
2016-12-06 |
The Regents Of The University Of California |
Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
|
GB0514809D0
(en)
|
2005-07-19 |
2005-08-24 |
Glaxo Group Ltd |
Compounds
|
US20080032960A1
(en)
|
2006-04-04 |
2008-02-07 |
Regents Of The University Of California |
PI3 kinase antagonists
|
EP2170057A4
(en)
*
|
2007-08-02 |
2012-02-15 |
Southern Res Inst |
5'-SUBSTITUTED ADENOSYNE, THEIR PREPARATION AND THEIR USE AS AN INHIBITORS OF S-ADENOSYLMETHIONINE DECARBOXYLASE
|
WO2009046448A1
(en)
|
2007-10-04 |
2009-04-09 |
Intellikine, Inc. |
Chemical entities and therapeutic uses thereof
|
US8648085B2
(en)
|
2007-11-30 |
2014-02-11 |
Boehringer Ingelheim International Gmbh |
1, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disorders
|
NZ613219A
(en)
|
2008-01-04 |
2014-11-28 |
Intellikine Llc |
Heterocyclic containing entities, compositions and methods
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
PL2231689T3
(pl)
|
2008-01-18 |
2017-01-31 |
Inst Of Organic Chemistry And Biochemistry Of The Acad Of Sciences Of The Czech Republic |
Nowe 7-deazapurynowe nukleozydy o właściwościach cytostatycznych
|
JP5547099B2
(ja)
|
2008-03-14 |
2014-07-09 |
インテリカイン, エルエルシー |
キナーゼ阻害剤および使用方法
|
WO2009114874A2
(en)
|
2008-03-14 |
2009-09-17 |
Intellikine, Inc. |
Benzothiazole kinase inhibitors and methods of use
|
UA105362C2
(xx)
|
2008-04-02 |
2014-05-12 |
Бьорингер Ингельхайм Интернациональ Гмбх |
Похідні 1-гетероцикліл-1,5-дигідропіразоло$3,4-d]піримідин-4-ону та їх застосування як модулятори pde9a$производные 1-гетероциклил-1,5-дигидропиразоло$3,4-d] пиримидин-4-она и их применение в качестве модуляторов pde9a
|
CN102124009B
(zh)
|
2008-07-08 |
2014-07-23 |
因特利凯公司 |
激酶抑制剂及其使用方法
|
US20110224223A1
(en)
|
2008-07-08 |
2011-09-15 |
The Regents Of The University Of California, A California Corporation |
MTOR Modulators and Uses Thereof
|
GB0815968D0
(en)
*
|
2008-09-03 |
2008-10-08 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
EA201100446A1
(ru)
|
2008-09-08 |
2011-10-31 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Пиразолопиримидины и их применение для лечения нарушений цнс
|
WO2010036380A1
(en)
|
2008-09-26 |
2010-04-01 |
Intellikine, Inc. |
Heterocyclic kinase inhibitors
|
AU2009305669A1
(en)
|
2008-10-16 |
2010-04-22 |
The Regents Of The University Of California |
Fused ring heteroaryl kinase inhibitors
|
US8476431B2
(en)
|
2008-11-03 |
2013-07-02 |
Itellikine LLC |
Benzoxazole kinase inhibitors and methods of use
|
JP2012521359A
(ja)
*
|
2009-03-20 |
2012-09-13 |
アリオス バイオファーマ インク. |
置換されたヌクレオシドアナログおよびヌクレオチドアナログ
|
MY156377A
(en)
|
2009-03-31 |
2016-02-15 |
Boehringer Ingelheim Int |
1-heterocycl-1, 5-dihydro-pyrazolo [3 , 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
|
WO2010121576A2
(en)
*
|
2009-04-22 |
2010-10-28 |
Institute Of Organic Chemistry And Biochemistry Ascr,V.V.I. |
Novel 7-deazapurine nucleosides for therapeutic uses
|
EP2427195B1
(en)
|
2009-05-07 |
2019-05-01 |
Intellikine, LLC |
Heterocyclic compounds and uses thereof
|
US8980899B2
(en)
|
2009-10-16 |
2015-03-17 |
The Regents Of The University Of California |
Methods of inhibiting Ire1
|
ES2593256T3
(es)
|
2010-05-21 |
2016-12-07 |
Infinity Pharmaceuticals, Inc. |
Compuestos químicos, composiciones y métodos para las modulaciones de cinasas
|
BR112013003097B1
(pt)
|
2010-08-12 |
2021-03-16 |
Boehringer Ingelheim International Gmbh |
6-cicloalquil-pirazolopirimidinonas e composição farmacêutica
|
GEP20156313B
(en)
|
2010-09-22 |
2015-07-10 |
Alios Biopharma Inc |
Substituted nucleotide analogs
|
CA2817577A1
(en)
|
2010-11-10 |
2012-05-18 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
UA115767C2
(uk)
|
2011-01-10 |
2017-12-26 |
Інфініті Фармасьютікалз, Інк. |
Способи отримання ізохінолінонів і тверді форми ізохінолінонів
|
US8809345B2
(en)
|
2011-02-15 |
2014-08-19 |
Boehringer Ingelheim International Gmbh |
6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
|
CN106619647A
(zh)
|
2011-02-23 |
2017-05-10 |
因特利凯有限责任公司 |
激酶抑制剂的组合及其用途
|
US9056877B2
(en)
|
2011-07-19 |
2015-06-16 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US8969363B2
(en)
|
2011-07-19 |
2015-03-03 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
PE20141371A1
(es)
|
2011-08-29 |
2014-10-13 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y usos de los mismos
|
EP2751112B1
(en)
|
2011-09-02 |
2019-10-09 |
The Regents of The University of California |
Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
|
EP2794630A4
(en)
|
2011-12-22 |
2015-04-01 |
Alios Biopharma Inc |
SUBSTITUTED PHOSPHORTHIOAT NUCLEOTIDE ANALOGUE
|
CN104321333A
(zh)
|
2012-03-21 |
2015-01-28 |
沃泰克斯药物股份有限公司 |
硫代氨基磷酸酯核苷酸前药的固体形式
|
WO2013142157A1
(en)
|
2012-03-22 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
JP2015532287A
(ja)
|
2012-09-26 |
2015-11-09 |
ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア |
Ire1の調節
|
US9481667B2
(en)
|
2013-03-15 |
2016-11-01 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
US9724354B2
(en)
|
2013-03-22 |
2017-08-08 |
Millennium Pharmaceuticals, Inc. |
Combination of catalytic mTORC1/2 inhibitors and selective inhibitors of Aurora A kinase
|
WO2015051241A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
EA201690713A1
(ru)
|
2013-10-04 |
2016-08-31 |
Инфинити Фармасьютикалз, Инк. |
Гетероциклические соединения и их применения
|
DK3119397T3
(da)
|
2014-03-19 |
2022-03-28 |
Infinity Pharmaceuticals Inc |
Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser
|
WO2015160975A2
(en)
|
2014-04-16 |
2015-10-22 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
US9708348B2
(en)
|
2014-10-03 |
2017-07-18 |
Infinity Pharmaceuticals, Inc. |
Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
|
AU2014277740B1
(en)
*
|
2014-12-17 |
2016-02-25 |
Institute of Organic Chemistry and Biochemistry, ASCR, v.v.i. |
Novel substituted 7-deazapurine ribonucleosides for therapeutic uses
|
AU2016322552B2
(en)
|
2015-09-14 |
2021-03-25 |
Infinity Pharmaceuticals, Inc. |
Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
|
WO2017161116A1
(en)
|
2016-03-17 |
2017-09-21 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
KR20190033526A
(ko)
|
2016-06-24 |
2019-03-29 |
인피니티 파마슈티칼스, 인코포레이티드 |
병용 요법
|
EP3541396A4
(en)
*
|
2016-11-18 |
2020-07-22 |
Arcus Biosciences, Inc. |
CD73-MEDIATED IMMUNOSUPPRESSION INHIBITORS
|
CN110687232A
(zh)
*
|
2018-07-04 |
2020-01-14 |
郑州泰丰制药有限公司 |
用高效液相色谱检测l-氯糖差向异构体的方法
|
WO2020206289A1
(en)
*
|
2019-04-05 |
2020-10-08 |
Prelude Therapeutics, Incorporated |
Selective inhibitors of protein arginine methyltransferase 5
|